鼻咽癌放化疗患者健康教育效果评价指标体系的构建

Establishment of an evaluation index system for health education among nasopharyngeal carcinoma patients with radio-chemotherapy

目的 构建鼻咽癌放化疗患者健康教育效果评价指标体系,为护理工作者评价鼻咽癌放化疗患者健康教育效果,开展针对性的健康教育与指导工作提供理论依据。方法 2021年3月-7月,组建多学科研究团队,以知信行理论为基础,通过文献检索、半结构式访谈法、德尔菲专家函询法及层次分析法,确定鼻咽癌放化疗患者健康教育效果评价指标体系及各指标权重。结果 2轮函询的有效问卷回收率分别为85.0%和100%,专家权威程度系数分别为0.932、0.935;2轮函询各级指标的肯德尔和谐系数分别为0.235~0.326、0.302~0.419(P<0.01)。最终构建包括3个一级指标、19个二级指标和73个三级指标的鼻咽癌放化疗患者健康教育效果评价指标体系。结论 该研究构建的鼻咽癌放化疗患者健康教育效果评价指标体系,可为临床护理人员进行全面、高效的健康教育效果评价提供统一参考。

Objective We aimed to establish an evaluation index system for health education among patients with nasopharyngeal carcinoma(NPC) who are undergoing radio-chemotherapy. As a theoretical basis,this system may be applied by the clinical nurses to carry out targeted health education and guidance among NPC patients undergoing radio-chemotherapy and to evaluate the effect of health education. Methods From March to July 2021,we constituted a structured multidisciplinary research team,including oncologists,nurse specialists,nutritionists,et al,based on the theory of Knowledge-Belief-Practice. Literature review,semi-structured interviews,as well as the Delphi method and Multi-dimensional Analytic Hierarchy Process,were used to establish a framework of the evaluation index system and set weighted value for each evaluation index. Results The response rates of the 2 rounds of expert consultations are 85.0% and 100%.The expert authority coefficients are 0.932 and 0.935,respectively.The total Kendall harmony coefficients of the 2 rounds of expert consultations are 0.235~0.326 and 0.302~0.419(P<0.01).As a result,we built up an evaluation index system of health education which comprised 3 first-level indexes,19second-level indexes and 73 third-level indexes for NPC patients undergoing radio-chemotherapy. Conclusion The evaluation index system may provide evidence and a practice tool for clinical nurses in conducting a comprehensive and efficient evaluation of health education among NPC patients undergoing radio-chemotherapy.